EUVIMEDEUVIMED entdecken
Crossref

Ezetimibe ameliorates cisplatin‐induced nephrotoxicity: A novel therapeutic approach via modulating AMPK /Nrf2/ TXNIP signaling

Nevine Fathy iD, Shaimaa Farouk iD, Rabab H Sayed iD, Atef Tadros Fahim iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202302019r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Nevine Fathy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Cisplatin, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin (Cis) is among the most powerful antineoplastic medications, nevertheless, its serious side effects; particularly nephrotoxicity designates a major concern. Previous studies reported that ezetimibe (Eze), a well‐known antihyperlipidemic drug, exerts additional trivial pharmacological effects. In this work, we displayed Eze as an intriguing protective candidate in a cisplatin‐induced nephrotoxicity rat model through AMPK activation. Eze (10 mg/kg, p.o.) was administered for two weeks and Cis (10 mg/kg, i.p.) was administered on the 10th day to induce nephrotoxicity in male Wistar rats. Treatment with Eze greatly augmented the phosphorylation of adenosine 5′‐monophosphate‐activated protein kinase (AMPK) and the antioxidant regulator; nuclear factor erythroid 2‐related factor 2 (Nrf2), thus, mitigating oxidative injury through induction of the antioxidant enzymes, such as heme oxygenase‐1 (HO‐1) and glutathione reductase (GR). As well, Eze relieved inflammation by reducing protein expression of thioredoxin‐interacting protein (TXNIP) and nucleotide‐binding domain‐like receptor protein 3 (NLRP3), which led to a decrease in the release of caspase‐1, in addition to, the inflammatory markers IL‐18 and IL‐1 β. Besides, Eze ameliorated apoptosis in the renal cells through inhibiting the phosphorylated Apoptosis signal‐regulating kinase‐1(p‐ASK1), caspase‐3 and reducing Bax/Bcl2ratio. Correspondingly, histopathological examination corroborated the previous biochemical findings. Collectively, Eze exerts significant renal protection against Cis‐induced nephrotoxicity via antioxidant, anti‐inflammatory and anti‐apoptotic pathways that are probably mediated, at least partly, via activating AMPK/Nrf2/HO‐1 pathway and conquering both TXNIP/NLRP3 inflammasome and TXNIP/ASK1 signaling pathways. To confirm the protective effect of Eze via AMPK‐activation, an AMPK‐inhibitor, dorsomorphin (Dors), when co‐administered with Eze abolished its protective effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinNLR Family, Pyrin Domain-Containing 3 ProteinRatsMaleAnimalsAntioxidantsAMP-Activated Protein KinasesNF-E2-Related Factor 2EzetimibeRats, WistarOxidative StressCell Cycle Proteins

Stichwörter der Autor:innen

AMPK/Nrf2/HO-1 pathwayTXNIP/ASK1 signalingTXNIP/NLRP3 signalingcisplatin-induced nephrotoxicityezetimibe

Substanzen

CisplatinNLR Family, Pyrin Domain-Containing 3 ProteinAntioxidantsAMP-Activated Protein KinasesNF-E2-Related Factor 2EzetimibeTXNIP protein, ratCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • School of Pharmacy, Newgiza University, Giza, Egypt.

ORCID-Profile: Nevine Fathy, Shaimaa Farouk, Rabab H Sayed, Atef Tadros Fahim

Zitieren

APA

Fathy, N., Farouk, S., Sayed, R. H., & Fahim, A. T. (2024). Ezetimibe ameliorates cisplatin‐induced nephrotoxicity: A novel therapeutic approach via modulating AMPK /Nrf2/ TXNIP signaling. The FASEB Journal. https://doi.org/10.1096/fj.202302019r

Vancouver

Fathy N, Farouk S, Sayed RH, Fahim AT. Ezetimibe ameliorates cisplatin‐induced nephrotoxicity: A novel therapeutic approach via modulating AMPK /Nrf2/ TXNIP signaling. The FASEB Journal. 2024. doi:10.1096/fj.202302019r

BibTeX
@article{Fathy2024,
  author = {Fathy, Nevine and Farouk, Shaimaa and Sayed, Rabab H and Fahim, Atef Tadros},
  title = {Ezetimibe ameliorates cisplatin‐induced nephrotoxicity: A novel therapeutic approach via modulating AMPK /Nrf2/ TXNIP signaling},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202302019r}
}
Kostenlos starten →